Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis.

Gülen T, Hägglund H, Dahlén SE, Sander B, Dahlén B, Nilsson G.

Lancet. 2014 May 3;383(9928):1608. doi: 10.1016/S0140-6736(14)60585-7. No abstract available.

PMID:
24792857
[PubMed - indexed for MEDLINE]
2.

Interactive medical case. A rash hypothesis.

Ross JJ, Saavedra A, Vleugels RA, Liu A, Castells MC.

N Engl J Med. 2010 Jun 17;362(24):e69. doi: 10.1056/NEJMimc0903117. No abstract available.

PMID:
20560180
[PubMed - indexed for MEDLINE]
Free Article
3.

Refractory symptoms successfully treated with leukotriene inhibition in a child with systemic mastocytosis.

Turner PJ, Kemp AS, Rogers M, Mehr S.

Pediatr Dermatol. 2012 Mar-Apr;29(2):222-3. doi: 10.1111/j.1525-1470.2011.01576.x. Epub 2011 Nov 2.

PMID:
22044360
[PubMed - indexed for MEDLINE]
4.

Differential diagnosis of the patient with unexplained flushing/anaphylaxis.

Metcalfe DD.

Allergy Asthma Proc. 2000 Jan-Feb;21(1):21-4. Review.

PMID:
10748948
[PubMed - indexed for MEDLINE]
5.

Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.

Tolar J, Tope WD, Neglia JP.

N Engl J Med. 2004 Feb 12;350(7):735-6. No abstract available.

PMID:
14960756
[PubMed - indexed for MEDLINE]
Free Article
6.

Failure of montelukast to prevent anaphylaxis to diclofenac.

Enrique E, García-Ortega P, Gaig P, San Miguel MM.

Allergy. 1999 May;54(5):529-30. No abstract available.

PMID:
10380791
[PubMed - indexed for MEDLINE]
7.

Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.

Reicin A, White R, Weinstein SF, Finn AF Jr, Nguyen H, Peszek I, Geissler L, Seidenberg BC.

Arch Intern Med. 2000 Sep 11;160(16):2481-8.

PMID:
10979060
[PubMed - indexed for MEDLINE]
8.

Treatment of telangiectasia macularis eruptiva perstans with montelukast.

Cengizlier R, Hücümenoğlu S, Ozen A, Tülin Sayli R.

Allergol Immunopathol (Madr). 2009 Nov-Dec;37(6):334-6. doi: 10.1016/j.aller.2009.03.010. Epub . No abstract available.

PMID:
19913347
[PubMed - indexed for MEDLINE]
9.

Premedication with montelukast reduces local reactions of allergen immunotherapy.

Wöhrl S, Gamper S, Hemmer W, Heinze G, Stingl G, Kinaciyan T.

Int Arch Allergy Immunol. 2007;144(2):137-42. Epub 2007 May 25.

PMID:
17536222
[PubMed - indexed for MEDLINE]
10.

Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review.

Shaffer HC, Parsons DJ, Peden DB, Morrell D.

J Am Acad Dermatol. 2006 May;54(5 Suppl):S210-3. Review.

PMID:
16631942
[PubMed - indexed for MEDLINE]
11.

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.

Nayak AS, Philip G, Lu S, Malice MP, Reiss TF; Montelukast Fall Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2002 Jun;88(6):592-600.

PMID:
12086367
[PubMed - indexed for MEDLINE]
12.

Single-dose desloratadine and montelukast and allergen-induced late airway responses.

Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F, Boulet LP, Cockcroft DW.

Eur Respir J. 2009 Jun;33(6):1302-8. doi: 10.1183/09031936.00169008. Epub 2009 Jan 22.

PMID:
19164343
[PubMed - indexed for MEDLINE]
Free Article
13.

The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children.

Peroni DG, Piacentini GL, Pietrobelli A, Loiacono A, De Gasperi W, Sabbion A, Micciolo R, Boner AL.

Eur Respir J. 2002 Jul;20(1):104-7.

PMID:
12166555
[PubMed - indexed for MEDLINE]
Free Article
14.

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.

Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.

J Allergy Clin Immunol. 2000 May;105(5):917-22.

PMID:
10808172
[PubMed - indexed for MEDLINE]
15.

[Therapeutic options in idiopathic chronic urticaria].

Mora PM, González Pérez Mdel C, Jiménez Villarruel M, Rodriguez Castro E, Fogelbach GG.

Rev Alerg Mex. 2005 Mar-Apr;52(2):77-82. Spanish.

PMID:
16158780
[PubMed - indexed for MEDLINE]
16.

Recurrent near-syncope with flushing.

Suchard JR.

Acad Emerg Med. 1997 Jul;4(7):718-24.

PMID:
9223698
[PubMed - indexed for MEDLINE]
17.

[Systemic mastocytosis].

Sade K, Dotan I, Levo Y.

Harefuah. 2000 Sep;139(5-6):202-6, 245. Hebrew.

PMID:
11062953
[PubMed - indexed for MEDLINE]
18.

[Montelukast: new therapeutic option in patients with nasal polyps associated to respiratory allergic disease].

Almeida Arvizu V, Guidos Fogelbach G, Sánchez Sánchez B, Vásquez Nava F, Matta Campos J, López Medina L, Rivera Pérez J, Mejía Covarrubias F, Montero Mora P.

Rev Alerg Mex. 2005 Jul-Aug;52(4):151-8. Spanish.

PMID:
16268183
[PubMed - indexed for MEDLINE]
19.

Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis.

Saengpanich S, deTineo M, Naclerio RM, Baroody FM.

Arch Otolaryngol Head Neck Surg. 2003 May;129(5):557-62.

PMID:
12759270
[PubMed - indexed for MEDLINE]
20.

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.

Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.

Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9.

PMID:
14756468
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk